One of the drugs they commonly use is called anastrozole. Researchers are looking for ways to improve standard treatments. In this study, they were looking at a drug called AZD8931 together with ...

A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...

In addition, the results from the early phase II study in patients with breast cancer demonstrated a superior clinical efficacy of anastrozole at the 1mg daily dose compared with the 0.5mg daily dose.

Kisqali plus aromatase inhibitor improved outcomes across age and menopausal status in early hormone receptor–positive, ...

Do not take ARIANNA 1 if you are allergic to: Anastrozole, the active ingredient ... inhibitors may cause inflammation in tendons (see Side effects). At any sign of tendon pain or swelling ...

According to AZ, SERENA-6 is also the first pivotal trial to show the value of measuring circulating tumour DNA (ctDNA) to ...

A new genetic test called MammaPrint is helping many breast cancer patients. This test determines the risk of cancer ...

Camizestrant and continued therapy with CDK4/6 inhibition benefits patients who present with ESR1-mutated, ER+, HER2– ...

Switching to a new drug combination — camizestrant plus a CDK4/6 inhibitor — sooner may have positive results for advanced ...

AstraZeneca could become the first company to bring an oral selective oestrogen receptor degrader (SERD) drug to market as ... with aromatase inhibitors like anastrozole or letrozole.

Conventional breast-cancer treatments have never been more effective. But recently, doctors say more patients are opting for natural remedies instead.